MIB Agents OsteoBites and osTEAo

MIB Agents OsteoBites and osTEAo

By MIB Agents OsteosarcomaMedicineHealth & Fitness
Download on the App Store

MIB Agents OsteoBites and osTEAo episodes

  • Osteosarcoma OsteoBites S2 Ep 14: Lillian Guenther, MD Dana-Farber CI & Harvard Med School “CRISPR Screening to Identify Novel Genomic Targets"

    MIB Agents OsteoBites S2 Ep 14:  Lillian Guenther, MD from Dana-Farber Cancer Institute and Harvard Medical School.  Dr. Guenther will be talking about, “Utilizing CRISPR Screening to Identify Novel Genomic Targets for Osteosarcoma”

    ....
    Guest Information:
    Lillian Guenther, MD
    Dana Farber Cancer Institute
    ...
    Dr. Guenther received her bachelor degree from Brown University and her MD from SUNY Downstate College of Medicine. She spent one year as a Howard Hughes Medical Institute/NIH Research Scholar studying osteosarcoma in Dr. Lee Helman’s laboratory at the National Cancer Institute. Lily is currently an Instructor in Pediatrics at Harvard Medical School and performs research in the lab of Dr. Kimberly Stegmaier. She cares for pediatric cancer patients at Boston Children’s Hospital and in the Jimmy Fund Clinic at Dana-Farber Cancer Institute.  Dr. Guenther was a finalist for our OutSmarting Osteosarcoma Grant.  Our group of osteosarcoma families and Scientific Advisory Team found her research to be truly hopeful and innovative.
    ...
    Panelists
    Matt Allen, 2021 MIB Junior Board Member and Gamer Agents Leadership Team
    Maeve Smart, OsteoWarrior & 2021 MIB Jr. Board President
    Amy Woodchecke, Physician’s Assistant and Childhood Cancer Survivor.
    Ann Graham, OsteoWarrior & Executive Director of MIB Agents.
    ...
    Coming up next week, Dr. Katie Greenzang of Dana Farber Cancer Institute and Harvard Medical School on “What’s Next? Osteosarcoma Survivorship”
    ...
    MIB Agents is a leading pediatric #osteosarcoma nonprofit dedicated to Making It Better for our
    community of patients, caregivers, doctors, and researchers with the goal of less toxic, more effective treatments and a cure for this aggressive bone cancer. More information at www.mibagents.org
    ...
    LINKS
    Register: https://bit.ly/MIBobites
    OutRunning Osteosarcoma:.mibagents.org/outrunning
    Dr. Guenther Contact: [email protected]


    55 min
  • Osteosarcoma OsteoBites S2 E13: Scott Sauer, PhD on “Preventing Osteosarcoma Lethal Recurrence by Targeting Disseminated Tumor Cells”

    MIB Agents OsteoBites S2 Ep 13:  Scott Sauer, PhD on “Preventing Osteosarcoma Lethal Recurrence by Targeting Disseminated Tumor Cells”

    ...
    Guest Information:
    Scott Sauer, PhD
    Head of Preclinical Discovery
    Vuja De Sciences, Inc. (www.vujade-life.com)
    ...
    Dr. Scott Sauer is a cancer researcher with multidisciplinary training in the fields of cancer biology, immunotherapy and organic chemistry. This diverse expertise provides a unique perspective to address unmet medical needs in cancer recurrence and metastasis. Scott received his PhD at Duke University in organic chemistry and a BS from the University of Maryland. After his PhD work, Dr. Sauer began his postdoctoral training at the Duke University Medical Center. His postdoctoral work was in cancer biology focusing on mechanisms of therapeutic resistance and disease progression. During this time, Scott received numerous postdoctoral awards including his work on the interplay between cancer progression and environmental toxicants. Dr. Sauer’s work was among the top three finalists for our 2021 OutSmarting Osteosarcoma grant.
    ...
    Panelists
    Kara Skrubis, MIB Junior Board Member and OsteoWarrior
    Amy Woodcheke, Physician’s Assistant and Childhood Cancer Survivor
    Ann Graham, OsteoWarrior & Executive Director of MIB Agents
    ...
    What We Do PROGRAMS:
    ✨ End-of-Life MISSIONS
    ✨ Gamer Agents
    ✨ Warrior Mail
    ✨ Prayer Agents
    ✨ Healing Hearts Bereaved Parent Support
    ✨ Ambassador Agents - Peer Support

    EDUCATION for physicians, researchers and families:

    ✨ OsteoBites, weekly webinar & podcast with thought leaders and innovators in Osteosarcoma
    ✨ MIB Book: Osteosarcoma: From our Families to Yours

    RESEARCH

    ✨ Annual MIB FACTOR Research Conference
    ✨ Funding $100,000 annually for OS research
    ✨ MIB Testing & Research Directory
    ✨ The Osteosarcoma Project partner with Broad Institute of MIT and Harvard
    ....
    OsteoBites is made possible by listeners like you.  Please consider donating to MIB Agents or be an All Star Agent by being a monthly supporter.
    Kids are still dying with 40+ year old treatments. Help us MakeItBetter. www.mibagents.org
    Osteosarcoma Resources:  www.MIBagents.org/contact
    Dr. Sauer Contact: [email protected]
    Vuja De Sciences: https://vujade-life.com/
    MIB Limited Edition Sunflower Tee & Tank:  https://www.bonfire.com/make-it-better-together/

    41 min
  • Osteosarcoma OsteoBites S2 Ep12: Dan Prince, MD, MPH on “Regenerative Surgery for Bone Sarcomas”

    MIB Agents OsteoBites S2 Ep12: Dan Prince, MD on “Regenerative Surgery for Bone Sarcomas”

    ...
    Guest Information:
    Daniel Prince, MD, MPH
    Orthopedic Surgeon
    Memorial Sloan Kettering Cancer
    Education (MD): Yale University Medical School
    Board Certifications: Orthopedic Surgery
    ...
    Dr. Prince is an Orthopedic Surgeon from Memorial Sloan Kettering Cancer Center on the “MSK Kids” team, specializing in the care of children, adolescents, and young adults with bone tumors and other diseases of the bone. His research and expertise is in bone regeneration, which relies on the body’s natural abilities to regrow bone after a segment of bone is removed during cancer surgery.
    ...
    MIB Agents is a leading pediatric #osteosarcoma nonprofit dedicated to Making It Better for our community of patients, caregivers, doctors, and researchers with the goal of less toxic, more effective treatments and a cure for this aggressive bone cancer. More information at www.mibagents.org
    …
    What We Do
    PROGRAMS:

    ✨ End-of-Life MISSIONS

    ✨ Gamer Agents

    ✨ Warrior Mail

    ✨ Prayer Agents

    ✨ Healing Hearts Bereaved Parent Support

    ✨ Ambassador Agents - Peer Support

    EDUCATION for physicians, researchers and families:

    ✨ OsteoBites, weekly webinar & podcast with thought leaders and innovators in Osteosarcoma

    ✨ MIB Book: Osteosarcoma: From our Families to Yours

    RESEARCH

    ✨ Annual MIB FACTOR Research Conference

    ✨ Funding $100,000 annually for OS research

    ✨ MIB Testing & Research Directory

    ✨ The Osteosarcoma Project partner with Broad Institute of MIT and Harvard

    ....

    OsteoBites is made possible by listeners like you.  Please consider donating to MIB Agents or be a Super Agent by being a monthly supporter. More info on our *New* website, mibagents.org
    ...
    🔗
    Kids are still dying with 40+ year old treatments. Help us MakeItBetter. www.mibagents.org
    Daniel Prince, MD, MPH bit.ly/MIBprince
    Memorial Sloan Kettering Cancer Center www.mskcc.org
    OS Resource Kit Order Form www.mibagents.org - click on blue bar at top of page
    ...

    1 hr
  • Osteosarcoma OsteoBites S2 Ep 11: Ines Lohse, PhD on “Drug Sensitivity Testing for the Treatment Stratification of Cancer Patients”

    MIB Agents OsteoBites S2 Ep 11:  Ines Lohse, PhD on “Drug Sensitivity Testing for the Treatment Stratification of Cancer Patients”

    ...
    Guest Information:
    Ines Lohse, PhD
    Assistant Scientist
    University of Miami
    Center for Therapeutic Innovation
    ...
    Dr. Lohse received her PhD from the University of Zurich in 2011. After postdoctoral fellowships at the Princess Margaret Cancer Center (Toronto) and the University of Michigan, Dr. Lohse moved to the University of Miami to focus on the preclinical and early clinical development of novel technology and therapeutic options for cancer patients. The Ex Vivo Drug Sensitivity Testing Platform has been successfully tested in a pilot cohort of patients, including sarcoma.  It is currently in development to transition the platform to clinical routine.
    ...
    Panelists
    Mia Sandino, MIB Junior Board Member and OsteoWarrior
    Charlotte Murdoff, MIB Junior Board Member and OsteoWarrior
    Annika Vallejo, MIB Junior Board Member and OsteoWarrior Sibling
    Ann Graham, OsteoWarrior & Executive Director of MIB Agents.
    ...
    Coming up next week is Daniel Prince, MD, MPH Orthopedic Surgeon from Memorial Sloan Kettering Cancer Center on
    “Regenerative Surgery for Bone Sarcomas”.
    ...
    MIB Agents is a leading pediatric #osteosarcoma nonprofit dedicated to Making It Better for our
    community of patients, caregivers, doctors, and researchers with the goal of less toxic, more effective treatments and a cure for this aggressive bone cancer. More information at www.mibagents.org
    ...
    Register: https://bit.ly/MIBobites
    Osteosarcoma Resources:  www.MIBagents.org/contact
    Dr. Lohse Contact: [email protected]
    University of Miami Website: umiamihealth.org/sylvester-comprehensive-cancer-center/research/faculty/ines-lohse-phd

    56 min
  • Osteosarcoma OsteoBites S2 Ep 10: Sumit Gupta, MD, PhD, FRCPC “Long Term Mental Health Outcomes in Adolescents and Young Adults with Cancer”

    MIB Agents OsteoBites S2 Ep 10:  Sumit Gupta, MD, PhD, FRCPC “Long Term Mental Health Outcomes in Adolescents and Young Adults with Cancer”

    ...
    Guest Information:
    Sumit Gupta, MD, PhD, FRCPC
    Hospital for Sick Children, Staff Oncologist and Clinician Investigator
    University of Toronto, Associate Professor
    Institute for Health Policy, Management and Evaluation, Associate Professor
    Cancer Research Program at the Institute for Clinical Evaluative Sciences, Adjunct Scientist

    Dr. Gupta completed a PhD in Clinical Epidemiology from the University of Toronto, during which time he was supported by a CIHR Fellowship Award. He is one of the Assistant Chairs of the Lancet Oncology Commission on Sustainable Pediatric Cancer Care in low and middle income countries. Sumit has worked extensively with pediatric oncologists and policymakers throughout Latin America, the Caribbean, and India. He currently holds grant funding from The Garron Family Cancer Centre, CIHR and the Terry Fox Research Institute.Sumit Gupta, MD, PhD, FRCPC

    ...
    Panelists
    Amy Woodcheke, Physicians Assistant and Childhood Cancer Survivor
    Mia Sandino, MIB Junior Board Member and OsteoWarriors
    Ann Graham, OsteoWarrior & Executive Director of MIB Agents
    ...
    Coming up next week is Dr. Ines Lohse of University of Miami, Sylvester Comprehensive Cancer Center talking with us about “Drug Sensitivity Testing for the Treatment Stratification of Cancer Patients”
    ...
    MIB Agents is a leading pediatric #osteosarcoma nonprofit dedicated to Making It Better for our community of patients, caregivers, doctors, and researchers with the goal of less toxic, more effective treatments and a cure for this aggressive bone cancer. More information at www.mibagents.org
    ...
    Register: https://bit.ly/MIBobites
    Osteosarcoma Resources:  www.MIBagents.org/contact 
    Link Mentioned on this episode on ASCO BLOG: Addressing the Mental Health Needs of Adolescent and Young Adult Cancer Survivors
    https://connection.asco.org/blogs/addressing-mental-health-needs-adolescent-and-young-adult-cancer-survivors


    59 min
  • MIB Agents OsteoBites S2 Ep 9: Jane Yanagawa, MD, “Osteosarcoma Lung Metastases”

    MIB Agents OsteoBites S2 Ep 9: Jane Yanagawa, MD, “Osteosarcoma Lung Metastases”

    Guest Information:

    Jane Yanagawa, MD
    Associate Professor of Thoracic Surgery,
    UCLA David Geffen School of Medicine, Department of Surgery
    ...
    Dr. Yanagawa is a thoracic surgeon at the UCLA David Geffen School of Medicine, Department of Surgery.  She completed her residency at UCSD and her fellowship in Thoracic Surgery at Memorial Sloan-Kettering Cancer Center.
    ...
    Our panel today includes Amy Woodcheke, Physicians Assistant and Childhood Cancer Survivor.  And MIB Junior Board Members and OsteoWarriors Mia Sandino and Charlotte Murdoff.  I am your host, Ann Graham Executive Director of MIB Agents.
    ...
    Coming up next week is Sumit Gupta, MD, PhD who will be speaking on “Long Term Mental Health Outcomes in Adolescents and Young Adults with Cancer”
    ...
    MIB Agents is a leading pediatric #osteosarcoma nonprofit dedicated to Making It Better for our
    community of patients, caregivers, doctors, and researchers with the goal of less toxic, more effective treatments and a cure for this aggressive bone cancer. More information at www.mibagents.org
    ...
    Register: https://bit.ly/MIBobites
    Osteosarcoma Resources:  www.MIBagents.org/contact

    58 min
  • OsteoBites S2 Ep 8: Chand Khanna DVM, PhD, “A Comparative Approach To Metastasis: Biology and Therapy”

    MIB Agents OsteoBites S2 Ep 8: Chand Khanna DVM, PhD, “A Comparative Approach To Metastasis:  Biology and Therapy”

    Guest Information:

    Chand Khanna DVM, PhD
    Chief Science Officer, Ethos Veterinary Health
    President, President of Ethos Discovery

    Dr. Khanna is a well known osteosarcoma expert and researcher.  He is a board-certified diplomate of the American College of Veterinary Internal Medicine (Oncology) and an honorary Diplomate of the American College Veterinary Pathology. He received a PhD in Pathobiology from the University of Minnesota and then completed a postdoctoral fellowship in the Pediatric Oncology Branch of the National Cancer Institute where he led a laboratory focused on metastasis drug discovery and was the founding director of the NCI Comparative Oncology Program. Dr. Khanna is Chief Science Officer with Ethos Veterinary Health, and President of Ethos Discovery, a nonprofit incubator of scientific innovation.

    ...
    Our panel today includes Amy Woodchecke BS, MHS, PA-C,, a childhood cancer survivor and pediatric oncology Physician’s Assistant.  I am your host, Ann Graham Executive Director of MIB Agents.
    ...
    Coming up in April with OsteoExperts Making It Better including; Jane Yanagawa, MD, Sumit Gupta, MD, PhD, Ines Lohse, PhD and Daniel Prince, MD.
    ...
    MIB Agents is a leading pediatric #osteosarcoma nonprofit dedicated to Making It Better for our
    community of patients, caregivers, doctors, and researchers with the goal of less toxic, more effective treatments and a cure for this aggressive bone cancer. More information at www.mibagents.org
    ...
    Register: https://bit.ly/MIBobites
    Osteosarcoma Resources:  www.MIBagents.org/contact
    Contact Dr. Khanna via Ethos Vet: [email protected] or Donna Reis at [email protected]

    1 hr
  • OsteoBites S2 Ep7: Corrie Painter, PhD “The Osteosarcoma Project, Patient-Partnered Research Update”

    MIB Agents OsteoBites S2 Ep7: Corrie Painter, PhD “The Osteosarcoma Project, Patient-Partnered Research Update”

    Guest Information:

    Corrie Painter, PhD
    Deputy Director, Count Me In. OSProject.org
    Broad Institute of MIT & Harvard

    Corrie Painter, PhD is the Associate Director of Count Me In and is a research scientist at the Broad Institute of MIT and Harvard.  A trained cancer researcher with a Ph.D. in biochemistry, she completed her postdoctoral work in cancer immunology, focused on melanoma. In 2010, Painter was diagnosed with angiosarcoma. She has combined her cancer advocacy and scientific background to engage with patients in order to build and carry out patient-partnered genomics studies. She is also the co-founder of Angiosarcoma Awareness Inc.

    ...

    Our panel today includes 2021 MIB Junior Board Member Shannon McCormack, 2020 Junior Board Member Ryan Kennington and Amy Woodchecke BS, MHS, PA-C,, a childhood cancer survivor and pediatric oncology Physician’s Assistant.  I am your host, Ann Graham Executive Director of MIB Agents.

    ...

    Panelists Information:

    Amy Woodcheke, BS, MHS, PA-C
    Shannon McCormack, 2021 MIB Junior Board Member & OsteoWarrior Sibling
    Ryan Kennington, 2020 MIB Junior Board Member & OsteoWarrior
    Hosted By Ann Graham, MIB AgentsExecutive Director & OsteoWarrior
    ...

    The rest of March, we will be taking a break.  April is packed with OsteoExperts Making It Better including; Chand Khanna, DVM, PhD, Jane Yanagawa, MD, Sumit Gupta, MD, PhD, Ines Lohse, PhD and Daniel Prince, MD.

    ...

    MIB Agents is a leading pediatric #osteosarcoma nonprofit dedicated to Making It Better for our

    community of patients, caregivers, doctors, and researchers with the goal of less toxic, more effective treatments and a cure for this aggressive bone cancer. More information at www.mibagents.org

    ...

    Register: https://bit.ly/MIBobites

    53 min
  • OsteoBites S2 Ep6: Brian Van Tine, MD, PhD on “Osteosarcoma Tumor Metabolism”

    MIB Agents OsteoBites S2 Ep6: Brian Van Tine, MD, PhD on “Osteosarcoma Tumor Metabolism”


    Guest Information:

    Brian Van Tine, M.D., Ph.D.

    Associate Professor of Medicine
    Associate Professor of Pediatrics
    Washington University in St Louis, Missouri
    Sarcoma Program Director
    Co-Director of the Adolescence and Young Adult Program
    Alvin J. Siteman Cancer Center.

    Dr. Van Tine has been the head of the Sarcoma Clinical Trials Program at Washington University for the past decade. Dr. Van Tine’s laboratory is dedicated to understanding the metabolism of sarcoma, and has recently developed a dual metabolic therapy for the treatment of complex cytogenetic sarcomas based on the exploitation of argininosuccinate synthetase 1 deficiency and glutaminase inhibition.

    ...
    MIB Agents is a leading pediatric #osteosarcoma nonprofit dedicated to Making It Better for our community of patients, caregivers, doctors, and researchers with the goal of less toxic, more effective treatments and a cure for this aggressive bone cancer. More information at www.mibagents.org
    …

    What We Do at MIB Agents:

    PROGRAMS:

    ✨ End-of-Life MISSIONS

    ✨ Gamer Agents
    ✨ Agent Writers
    ✨ Prayer Agents
    ✨ Healing Hearts Bereaved Parent Support
    ✨ Ambassador Agents - Peer Support

    EDUCATION for physicians, researchers and families:

    ✨ OsteoBites, weekly webinar & podcast with thought leaders and innovators in Osteosarcoma
    ✨ MIB Book: Osteosarcoma: From our Families to Yours

    RESEARCH:

    ✨ Annual MIB FACTOR Research Conference
    ✨ Funding $100,000 annually for OS research
    ✨ MIB Testing & Research Directory
    ✨ The Osteosarcoma Project partner with Broad Institute of MIT and Harvard

    ....

    OsteoBites is made possible by listeners like you.  Please consider donating to MIB Agents or be a Super Agent by being a monthly supporter. More info on our *New* website, mibagents.org
    ...

    Kids are still dying with 40+ year old treatments. Help us MakeItBetter.

    🔗 https://www.mibagents.org

    1 hr
  • OsteoBites S2 Ep5: Robbie Majzner, MD on “Unleashing the Pediatric Immune System Against Osteosarcoma and Other Solid Tumors”

    MIB Agents OsteoBites S2 Ep5: Robbie Majzner, MD on “Unleashing the Pediatric Immune System Against Osteosarcoma and Other Solid Tumors”

    Guest Information:

    Robbie Majzner, MD
    Assistant Professor of Pediatrics
    Stanford University School of Medicine
    ...
    Dr. Majzner is an Assistant Professor of Pediatrics at Stanford University School of Medicine. After graduating with a BA from Columbia University, he attended Harvard Medical School, where he developed an interest in pediatric oncology. He completed his residency at NY Presbyterian-Columbia and fellowship in pediatric hematology-oncology at Johns Hopkins and the National Cancer Institute. During his fellowship, he cared for some of the first pediatric patients to receive CD19 chimeric antigen receptor (CAR) T cells.  Witnessing the success of CAR T cells in these patients drove Dr. Majzner to the laboratory, where he focuses on developing immunotherapies for children with incurable solid tumor cancers. His laboratory work aims to generate highly efficacious CAR T cells and to find new immunotherapeutic strategies to treat pediatric cancer.
    ...
    Our panel today includes 2021 MIB Junior Board Members Charlotte Murdoff Mia Sandino, and Amy Woodchecke, a childhood cancer survivor and pediatric oncology Physician’s Assistant.  I am your host, Ann Graham President of MIB Agents.
    ...
    Panelists Information:
    Amy Woodcheke, BS, MHS, PA-C
    Charlotte Murdoff, 2021 MIB Junior Board Member & OsteoWarrior
    Mia Sandino, 2021 MIB Junior Board Member & OsteoWarrior
    Hosted By Ann Graham, MIB Agents President & OsteoWarrior
    ...
    Next week we will talk with Dr. Brian Van Tine of Washington University in St. Louis on Osteosarcoma Tumor Metabolism.
    ...
    MIB Agents is a leading pediatric #osteosarcoma nonprofit dedicated to Making It Better for our
    community of patients, caregivers, doctors, and researchers with the goal of less toxic, more effective treatments and a cure for this aggressive bone cancer. More information at www.mibagents.org
    ...
    Register: https://bit.ly/MIBobites

    1 hr 6 min

About MIB Agents OsteoBites and osTEAo

From the publisher's feed

Each week, MIB Agents talks with the leaders and innovators in osteosarcoma surgery, research, treatment and advocacy. Questions are taken during the webinar and are included in each podcast. More…

More shows like MIB Agents OsteoBites and osTEAo

The Deep C by Snack Labs

The Deep C

4 Listeners